JP2004525905A5 - - Google Patents

Download PDF

Info

Publication number
JP2004525905A5
JP2004525905A5 JP2002567291A JP2002567291A JP2004525905A5 JP 2004525905 A5 JP2004525905 A5 JP 2004525905A5 JP 2002567291 A JP2002567291 A JP 2002567291A JP 2002567291 A JP2002567291 A JP 2002567291A JP 2004525905 A5 JP2004525905 A5 JP 2004525905A5
Authority
JP
Japan
Prior art keywords
composition
formula
enantiomer
phenyl
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002567291A
Other languages
English (en)
Japanese (ja)
Other versions
JP4276839B2 (ja
JP2004525905A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from US10/081,606 external-priority patent/US7122576B2/en
Publication of JP2004525905A publication Critical patent/JP2004525905A/ja
Publication of JP2004525905A5 publication Critical patent/JP2004525905A5/ja
Application granted granted Critical
Publication of JP4276839B2 publication Critical patent/JP4276839B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002567291A 2001-02-27 2002-02-21 双極性障害の予防もしくは治療における使用のためのカルバメート化合物 Expired - Fee Related JP4276839B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27168001P 2001-02-27 2001-02-27
US10/081,606 US7122576B2 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating bipolar disorder
PCT/US2002/005425 WO2002067924A1 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating bipolar disorder

Publications (3)

Publication Number Publication Date
JP2004525905A JP2004525905A (ja) 2004-08-26
JP2004525905A5 true JP2004525905A5 (cg-RX-API-DMAC7.html) 2005-12-22
JP4276839B2 JP4276839B2 (ja) 2009-06-10

Family

ID=26765743

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002567291A Expired - Fee Related JP4276839B2 (ja) 2001-02-27 2002-02-21 双極性障害の予防もしくは治療における使用のためのカルバメート化合物

Country Status (25)

Country Link
US (1) US7122576B2 (cg-RX-API-DMAC7.html)
EP (1) EP1368021B1 (cg-RX-API-DMAC7.html)
JP (1) JP4276839B2 (cg-RX-API-DMAC7.html)
KR (1) KR20030074849A (cg-RX-API-DMAC7.html)
CN (1) CN1250214C (cg-RX-API-DMAC7.html)
AT (1) ATE378046T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002242226B2 (cg-RX-API-DMAC7.html)
BR (1) BR0207832A (cg-RX-API-DMAC7.html)
CA (1) CA2439292A1 (cg-RX-API-DMAC7.html)
CY (1) CY1107199T1 (cg-RX-API-DMAC7.html)
CZ (1) CZ296641B6 (cg-RX-API-DMAC7.html)
DE (1) DE60223506T2 (cg-RX-API-DMAC7.html)
DK (1) DK1368021T3 (cg-RX-API-DMAC7.html)
ES (1) ES2295320T3 (cg-RX-API-DMAC7.html)
HU (1) HUP0303261A3 (cg-RX-API-DMAC7.html)
IL (2) IL157589A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA03007716A (cg-RX-API-DMAC7.html)
MY (1) MY133370A (cg-RX-API-DMAC7.html)
NO (1) NO20033799L (cg-RX-API-DMAC7.html)
NZ (1) NZ527989A (cg-RX-API-DMAC7.html)
PL (1) PL364640A1 (cg-RX-API-DMAC7.html)
PT (1) PT1368021E (cg-RX-API-DMAC7.html)
RS (1) RS50680B (cg-RX-API-DMAC7.html)
RU (1) RU2286147C2 (cg-RX-API-DMAC7.html)
WO (1) WO2002067924A1 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ553813A (en) * 2004-09-16 2010-09-30 Janssen Pharmaceutica Nv Use of 2-phenyl-1, 2-ethanediol-(DI) carbamates for treating epileptogenesis and epilepsy
FR2884714B1 (fr) * 2005-04-20 2011-05-06 Servier Lab Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement des troubles bipolaires
US20070021501A1 (en) * 2005-07-12 2007-01-25 Twyman Roy E Methods of treating epileptogenesis
EP1928451B1 (en) * 2005-07-26 2011-12-28 SK Biopharmaceuticals Co., LTD Methods for treating substance-related disorders
BRPI0718324A2 (pt) * 2006-10-30 2013-11-26 Sk Holdings Métodos para o tratamento de depressão.
HUP0700353A2 (en) * 2007-05-18 2008-12-29 Richter Gedeon Nyrt Metabolites of (thio)carbamoyl-cyclohexane derivatives
HUP0700370A2 (en) * 2007-05-24 2009-04-28 Richter Gedeon Nyrt Use of (thio)-carbamoyl-cyclohexane derivatives in the manufacture of a medicament for the treatment of acute mania
US7875610B2 (en) * 2007-12-03 2011-01-25 Richter Gedeon Nyrt. Pyrimidinyl-piperazines useful as D3/D2 receptor ligands
JP4409630B2 (ja) * 2008-02-21 2010-02-03 田辺三菱製薬株式会社 経口投与用固形製剤
HRP20150196T1 (hr) 2008-07-16 2015-06-05 Richter Gedeon Nyrt. Farmaceutske formulacije s ligandima receptora dopamina
HU230067B1 (hu) 2008-12-17 2015-06-29 Richter Gedeon Nyrt Új piperazin só és eljárás előállítására
HUP0800765A2 (en) 2008-12-18 2010-11-29 Richter Gedeon Nyrt A new process for the preparation of piperazine derivatives and their hydrochloric salts
HUP0800766A2 (en) 2008-12-18 2010-11-29 Richter Gedeon Vegyeszet Process for the preparation of piperazine derivatives
US11274087B2 (en) 2016-07-08 2022-03-15 Richter Gedeon Nyrt. Industrial process for the preparation of cariprazine
KR102635938B1 (ko) * 2016-12-14 2024-02-13 에스케이바이오팜 주식회사 양극성 장애의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도
US11547707B2 (en) 2019-04-10 2023-01-10 Richter Gedeon Nyrt. Carbamoyl cyclohexane derivatives for treating autism spectrum disorder

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3278380A (en) 1962-02-06 1966-10-11 Armour Pharma Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en) 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol

Similar Documents

Publication Publication Date Title
JP2004525905A5 (cg-RX-API-DMAC7.html)
JP2004533415A5 (cg-RX-API-DMAC7.html)
JP2009531376A5 (cg-RX-API-DMAC7.html)
JP2004527492A5 (cg-RX-API-DMAC7.html)
JP2006526590A5 (cg-RX-API-DMAC7.html)
JP2010502730A5 (cg-RX-API-DMAC7.html)
JP2007511504A5 (cg-RX-API-DMAC7.html)
JP2005508349A5 (cg-RX-API-DMAC7.html)
JP2009506119A5 (cg-RX-API-DMAC7.html)
JP2011519865A5 (cg-RX-API-DMAC7.html)
JP2006504738A5 (cg-RX-API-DMAC7.html)
JP2002527414A5 (cg-RX-API-DMAC7.html)
RU2003128984A (ru) Производные карбаматов для использования для лечения боли
JPWO2023195529A5 (cg-RX-API-DMAC7.html)
JP2019520344A5 (cg-RX-API-DMAC7.html)
JP2004529114A5 (cg-RX-API-DMAC7.html)
RU2003128996A (ru) Карбаматы для применения для предотвращения или лечения биполярного расстройства
CA2439475A1 (en) Carbamate compounds for use in preventing or treating bipolar disorder
JP2004523556A5 (cg-RX-API-DMAC7.html)
JP2002509858A5 (cg-RX-API-DMAC7.html)
BR0112713A (pt) "compostos de carbamato para uso na prevenção ou tratamento de dor neuropática e dor associada a cefaléia em cacho e hemicrânia
CA2439480A1 (en) Carbamate compounds for use in preventing or treating psychotic disorders
JP2007518798A5 (cg-RX-API-DMAC7.html)
CA2523253A1 (en) Methyl indoles and methyl pyrrolopyridines as alpha-1 adrenergic agonists
JP2013507438A5 (cg-RX-API-DMAC7.html)